Medacta Group (MEDGF) Short Interest Ratio & Short Volume $83.91 0.00 (0.00%) As of 05/1/2025 Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartHeadlinesShort InterestBuy This Stock Medacta Group Short Interest DataMedacta Group (MEDGF) has a short interest of 18,900 shares. This marks a -61.27% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 200 shares to cover all short positions.Current Short Interest18,900 sharesPrevious Short Interest48,800 sharesChange Vs. Previous Month-61.27%Dollar Volume Sold Short$1.59 millionShort Interest Ratio0.0 Days to CoverLast Record DateApril 15, 2025Today's Trading Volume0 sharesAverage Trading Volume200 sharesToday's Volume Vs. Average0% Short Selling Medacta Group? Sign up to receive the latest short interest report for Medacta Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMEDGF Short Interest Over TimeMEDGF Days to Cover Over TimeMEDGF Percentage of Float Shorted Over Time Medacta Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202518,900 shares $1.59 million -61.3%N/A0 $83.91 3/31/202548,800 shares $4.09 million +63.2%N/A0 $83.91 3/15/202529,900 shares $2.51 million No ChangeN/A0 $83.91 2/28/202529,900 shares $2.51 million No ChangeN/A0 $83.91 2/15/202529,900 shares $2.51 million +56.5%N/A0 $83.91 1/31/202519,100 shares $1.60 million No ChangeN/A0 $83.91 1/15/202519,100 shares $1.60 million No ChangeN/A95.5 $83.91 12/31/202419,100 shares $1.60 million No ChangeN/A191 $83.91 12/15/202419,100 shares $1.60 million -9.5%N/A0 $83.91 11/30/202421,100 shares $1.77 million -1.9%N/A0 $83.91 Get the Latest News and Ratings for MEDGF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medacta Group and its competitors with MarketBeat's FREE daily newsletter. 11/15/202421,500 shares $1.80 million -0.9%N/A0 $83.91 10/31/202421,700 shares $1.82 million +61.9%N/A0 $83.91 10/15/202413,400 shares $1.12 million -10.7%N/A0 $83.91 9/30/202415,000 shares $1.26 million -1.3%N/A0 $83.91 9/15/202415,200 shares $1.28 million -0.7%N/A0 $83.91 8/31/202415,300 shares $1.28 million -6.7%N/A0 $83.91 8/15/202416,400 shares $1.38 million +1.2%N/A0 $83.91 7/31/202416,200 shares $1.36 million -2.4%N/A0 $83.91 7/15/202416,600 shares $1.39 million -9.8%N/A0 $83.91 6/30/202418,400 shares $1.54 million +4.6%N/A0 $83.91 6/15/202417,600 shares $1.48 million -2.8%N/A0 $83.91 5/31/202418,100 shares $1.52 million +11.0%N/A0 $83.91 5/15/202416,300 shares $1.37 million -23.5%N/A163 $83.91 4/30/202421,300 shares $1.79 million +88.5%N/A0 $83.91 4/15/202411,300 shares $948,183.00 +29.9%N/A0 $83.91 3/31/20248,700 shares $730,017.00 +4.8%N/A0 $83.91 3/15/20248,300 shares $696,453.00 No ChangeN/A0 $83.91 2/29/20248,300 shares $696,453.00 -56.8%N/A0 $83.91 2/15/202419,200 shares $1.61 million No ChangeN/A0 $83.91 1/15/202420,500 shares $1.72 million +2.5%N/A0 $83.91 12/31/202320,000 shares $1.68 million -5.7%N/A0 $83.91 12/15/202321,200 shares $1.78 million +72.4%N/A0 $83.91 11/30/202312,300 shares $1.03 million -3.9%N/A0 $83.91 11/15/202312,800 shares $1.07 million +6.7%N/A0 $83.91 10/31/202312,000 shares $1.01 million -35.8%N/A0 $83.91 10/15/202318,700 shares $1.57 million +33.6%N/A0 $83.91 9/30/202314,000 shares $1.17 million +21.7%N/A0 $83.91 9/15/202311,500 shares $964,965.00 -5.0%N/A0 $83.91 8/31/202312,100 shares $1.02 million +2.5%N/A0 $83.91 8/15/202311,800 shares $990,138.00 -5.6%N/A0 $83.91Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 7/31/202312,500 shares $1.05 million +9.7%N/A0 $83.91 7/15/202311,400 shares $956,574.00 -10.2%N/A0 $83.91 6/30/202312,700 shares $1.07 million -18.6%N/A0 $83.91 6/15/202315,600 shares $1.31 million +4.0%N/A0 $83.91 5/31/202315,000 shares $1.26 million -5.1%N/A0 $83.91 5/15/202315,800 shares $1.33 million +30.6%N/A0 $83.91 4/30/202312,100 shares $1.02 million -4.7%N/A0 $83.91 4/15/202312,700 shares $1.07 million -16.5%N/A0 $83.91 3/31/202315,200 shares $1.28 million +18.8%N/A0 $83.91 3/15/202312,800 shares $1.07 million -0.8%N/A128 $83.91 2/28/202312,900 shares $1.08 million -5.8%N/A0 $83.91 2/15/202313,700 shares $1.15 million -2.1%N/A0 $83.91 1/31/202314,000 shares $1.17 million -2.8%N/A0 $83.91 1/15/202314,400 shares $1.21 million -3.4%N/A0 $83.91 12/30/202214,900 shares $1.25 million -1.3%N/A0 $83.91 12/15/202215,100 shares $1.27 million -9.0%N/A151 $83.91 11/30/202216,600 shares $1.39 million +1.8%N/A0 $83.91 11/15/202216,300 shares $1.37 million +3.8%N/A163 $83.91 10/31/202215,700 shares $1.32 million -11.3%N/A0 $83.91 10/15/202217,700 shares $1.49 million +12.0%N/A0 $83.91 9/30/202215,800 shares $1.33 million +690.0%N/A158 $83.91 9/15/20222,000 shares $172,655.00 -44.4%N/A20 $86.33 8/31/20223,600 shares $309,600.00 -5.3%N/A0 $86.00 8/15/20223,800 shares $326,800.00 +81.0%N/A0 $86.00 7/31/20222,100 shares $180,600.00 -44.7%N/A21 $86.00 7/15/20223,800 shares $326,800.00 +31.0%N/A38 $86.00 6/30/20222,900 shares $359,600.00 No ChangeN/A0 $124.00 6/15/20222,900 shares $359,600.00 -56.1%N/A0 $124.00 5/31/20226,600 shares $818,400.00 +73.7%N/A0 $124.00 5/15/20223,800 shares $471,200.00 -44.1%N/A0 $124.00 4/30/20226,800 shares $843,200.00 +1.5%N/A0 $124.00 4/15/20226,700 shares $830,800.00 +48.9%N/A0 $124.00 3/31/20224,500 shares $558,000.00 -73.5%N/A0 $124.00 3/15/202217,000 shares $2.11 million +6.9%N/A170 $124.00 2/28/202215,900 shares $2.27 million +9.7%N/A0 $143.00 2/15/202214,500 shares $2.07 million +400.0%N/A0 $143.00 1/31/20222,900 shares $414,700.00 +480.0%N/A29 $143.00 1/15/2022500 shares $0.00 No ChangeN/A5 $0.00 12/31/2021500 shares $71,500.00 -16.7%N/A5 $143.00 12/15/2021600 shares $85,800.00 +500.0%N/A0 $143.00 11/30/2021100 shares $14,300.00 -93.3%N/A1 $143.00 11/15/20211,500 shares $185,250.00 +36.4%N/A0 $123.50 10/29/20211,100 shares $135,850.00 -45.0%N/A11 $123.50 10/15/20212,000 shares $247,000.00 +100.0%N/A0 $123.50 9/30/20211,000 shares $123,500.00 +25.0%N/A0 $123.50 9/15/2021800 shares $98,800.00 -20.0%N/A0 $123.50 8/31/20211,000 shares $123,500.00 +100.0%N/A0 $123.50 8/13/2021500 shares $61,750.00 -16.7%N/A0 $123.50 7/30/2021600 shares $74,100.00 +50.0%N/A0 $123.50 7/15/2021400 shares $49,400.00 No ChangeN/A0 $123.50Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 6/30/2021400 shares $49,400.00 -81.0%N/A4 $123.50 6/15/20212,100 shares $259,350.00 +23.5%N/A21 $123.50 5/28/20211,700 shares $0.00 +240.0%N/A17 $0.00 MEDGF Short Interest - Frequently Asked Questions What is Medacta Group's current short interest? Short interest is the volume of Medacta Group shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 18,900 shares of MEDGF short. Learn More on Medacta Group's current short interest. Is Medacta Group's short interest increasing or decreasing? Medacta Group saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 18,900 shares, a drop of 61.3% from the previous total of 48,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Medacta Group stock? Short selling MEDGF is an investing strategy that aims to generate trading profit from Medacta Group as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medacta Group? A short squeeze for Medacta Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MEDGF, which in turn drives the price of the stock up even further. How often is Medacta Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MEDGF, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies BICO Group AB (publ) Short Squeeze Caliber Imaging & Diagnostics Short Squeeze CellaVision AB (publ) Short Squeeze Cochlear Short Squeeze Demant A/S Short Squeeze Drägerwerk AG & Co. KGaA Short Squeeze Electromedical Technologies Short Squeeze Embla Medical hf. Short Squeeze Evome Medical Technologies Short Squeeze GN Store Nord A/S Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:MEDGF) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medacta Group SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Medacta Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDGF Stock Free MEDGF Stock Alerts